抑制PARP1驱动ROS阻力在状癌细胞中.
bioRxiv : the preprint server for biology
|February 27, 2026
概括
染色体数的变异,或染色体数的变异,通过抑制Poly (ADP-Ribose) 聚合酶1 (PARP1) 来增强癌细胞对抗氧化应激的生存能力. 这种抑制促进了瘤转移,揭示了血管积分和癌症进展之间的新联系.
科学领域:
- 癌症生物学 癌症生物学
- 遗传学 是一个遗传学.
- 细胞应激反应的应激反应
背景情况:
- 被异常染色体数量所特征的形积分症在癌症中很常见,并与瘤进展有关.
- 形积分症影响癌症的分子机制在很大程度上是未知的.
- 对抗细胞死亡途径,特别是氧化应激的抗氧化作用中无积体的作用需要进一步阐明.
研究的目的:
- 调查形积分症对癌细胞存活的功能后果,并确定潜在的分子机制.
- 探索动脉积分,活性氧物种 (ROS) 耐药性和癌症转移之间的联系.
- 为了揭示新型调节器的阳积分介导的表型.
主要方法:
- 产生新型无体细胞模型.
- 对ROS的细胞死亡抗性的评估.
- 聚 ((ADP-Ribose) 聚合酶1 (PARP1) 的表达和活性分析.
- 全基因组的CRISPR查用于识别基因修饰剂.
- 在多个细胞系和人类瘤样本中进行验证.
主要成果:
- 无积体症对ROS介导的细胞死亡具有显著的抵抗力,独立于特定的染色体变化.
- 形细胞表现出抑制的Poly (ADP-Ribose) 聚合酶1 (PARP1) 表达和活性,抑制ROS诱导的细胞死亡 (共生细胞).
- 鉴定出CCAAT/增强体结合蛋白β (CEBPB) 是一个关键的转录因子,它介导了PARP1抑制和ROS抵抗在形细胞中,由 lysosomal功能障碍激活.
- 降低PARP1水平促进瘤转移,而PARP1恢复则抑制了转移.
结论:
- 积体促进癌细胞的存活和转移通过抑制PARP1,由CEBPB激活介导.
- 这一途径代表了一种新的机制,它将形状与增强的癌症进展和转移潜力联系起来.
- 向化-CEBPB-PARP1轴可能为癌症治疗提供新的治疗策略.
相关概念视频
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
The Retinoblastoma Gene
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Replicative Cell Senescence
4.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K
Negative Regulator Molecules
38.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K


